Physician profile
Mark Biebel
NPI 1447614797
$2,043.48
in general payments reported to CMS, 2019-2025
18 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $473 · 2023: $750 · 2024: $366 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $771.23 | 2021-2024 | Rezum Generator, Tria Firm, Lithovue |
| Astellas Pharma US INC | $264.72 | 2021-2024 | Myrbetriq |
| Teleflex LLC | $216.28 | 2022-2024 | Urolift |
| Procept Biorobotics Corporation | $179.05 | 2024-2025 | Aquabeam System |
| Myriad Genetic Laboratories, INC. | $148.62 | 2023-2024 | Prolaris |
| Coloplast Corp | $85.21 | 2023-2024 | Isiris Astent Removal Device |
| 180 Medical, INC. | $81.51 | 2022-2024 | Gentlecath, Gentlecath Glide |
| Convatec INC. | $52.26 | 2022-2023 | |
| Photocure INC | $44.39 | 2021 | |
| Accord Healthcare, INC. | $42.59 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $32.57 | 2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $25.11 | 2024 | |
| Tolmar, INC. | $20.54 | 2023 | |
| Endo Pharmaceuticals INC. | $18.78 | 2023 | Xiaflex |
| Olympus America INC. | $17.16 | 2024 | Soltive |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $15.14 | 2023 | |
| Edap Technomed INC | $14.50 | 2023 | |
| Dentsply Ih INC. | $13.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Biebel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.